UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 67

Sortiert nach

Impact médico-économique potentiel d’une organisation stricte du circuit de sortie des patients dans un service de chirurgie urologique

Progrès en urologie (Paris), 2018-11, Vol.28 (13), p.679-679

2018

Volltextzugriff (PDF)

Description des délais de prise en charge des cancers de la prostate en pratique courante

Progrès en urologie (Paris), 2020-11, Vol.30 (13), p.695-695

2020

Volltextzugriff (PDF)

Gold(i)-catalyzed 6-endo-dig azide-yne cyclization: efficient access to 2H-1,3-oxazines

Chemical communications (Cambridge, England), 2017-01, Vol.53 (4), p.736-739

2017

Volltextzugriff (PDF)

Tolerability of integrase inhibitors in a real-life setting

Journal of antimicrobial chemotherapy, 2017-06, Vol.72 (6), p.1752-1759

2017

Volltextzugriff (PDF)

Do We Need a New Sustainability Assessment Method for the Circular Economy? A Critical Literature Review

Frontiers in sustainability (Lausanne), 2021-01, Vol.1

2021

Volltextzugriff (PDF)

Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trial

Journal of antimicrobial chemotherapy, 2018-07, Vol.73 (7), p.1965-1971

2018

Volltextzugriff (PDF)

Body composition changes after switching from protease inhibitors to raltegravir: SPIRAL-LIP substudy

AIDS (London), 2012-02, Vol.26 (4), p.475-481

2012

Volltextzugriff (PDF)

Dual therapy with etravirine plus raltegravir for virologically suppressed HIV-infected patients: a pilot study

Journal of antimicrobial chemotherapy, 2014-03, Vol.69 (3), p.742-748

2014

Volltextzugriff (PDF)

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients

AIDS (London), 2004-09, Vol.18 (13), p.F27-F36

2004

Volltextzugriff (PDF)

A 24-week pilot study of dual maintenance therapy with raltegravir and lamivudine

AIDS (London), 2019-10, Vol.33 (12), p.1891-1896

2019

Volltextzugriff (PDF)

Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy

AIDS (London), 2006-01, Vol.20 (1), p.59-66

2006

Volltextzugriff (PDF)

Risk of intrauterine growth restriction among HIV-infected pregnant women: a cohort study

European journal of clinical microbiology & infectious diseases, 2015-02, Vol.34 (2), p.223-230

2015

Volltextzugriff (PDF)

Dolutegravir monotherapy in HIV-infected patients with sustained viral suppression

Journal of antimicrobial chemotherapy, 2016-07, Vol.71 (7), p.1975-1981

2016

Volltextzugriff (PDF)

Abacavir-based therapy does not affect biological mechanisms associated with cardiovascular dysfunction

AIDS (London), 2010-01, Vol.24 (3), p.F1-F9

2010

Volltextzugriff (PDF)

Differential subcutaneous adipose tissue gene expression patterns in a randomized clinical trial of efavirenz or lopinavir-ritonavir in antiretroviral-naive patients

Antimicrobial agents and chemotherapy, 2014-11, Vol.58 (11), p.6717-6723

2014

Volltextzugriff (PDF)

A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/emtricitabine in HIV-1-infected patients with virological suppression

Journal of acquired immune deficiency syndromes (1999), 2009-07, Vol.51 (3), p.290

2009

Volltextzugriff (PDF)

A maintenance 3-day-per-week schedule with the single tablet regimen efavirenz/emtricitabine/tenofovir disoproxil fumarate is effective and decreases sub-clinical toxicity

AIDS (London), 2018-07, Vol.32 (12), p.1633-1641

2018

Volltextzugriff (PDF)

L’économie Circulaire Est-Elle Bonne Pour l’Environnement? Essais Sur La Mesure De La Circularité

Lonca, Geoffrey

2020

Volltextzugriff (PDF)

Improvement of lipoatrophy by switching from efavirenz to lopinavir/ritonavir

HIV medicine, 2016-05, Vol.17 (5), p.340-349

2016

Volltextzugriff (PDF)

Incidence and causes of death in HIV‐infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area

HIV medicine, 2007-05, Vol.8 (4), p.251-258

2007

Volltextzugriff (PDF)

Gynecomastia among HIV-Infected Patients Is Associated with Hypogonadism: A Case-Control Study

Clinical infectious diseases, 2004-11, Vol.39 (10), p.1514-1519

2004

Volltextzugriff (PDF)

Metabolic, mitochondrial, renal and hepatic safety of enfuvirtide and raltegravir antiretroviral administration: Randomized crossover clinical trial in healthy volunteers

PloS one, 2019-05, Vol.14 (5), p.e0216712

2019

Volltextzugriff (PDF)

Subclinical cardiovascular disease in patients starting contemporary protease inhibitors

HIV medicine, 2018-08, Vol.19 (7), p.497-503

2018

Volltextzugriff (PDF)

L’internat d’oncologie en outre-mer français

Bulletin du cancer, 2022-02, Vol.109 (2), p.232-240

2022

Volltextzugriff (PDF)

Direct detection in clinical samples of multiple gene mutations causing resistance of Mycobacterium tuberculosis to isoniazid and rifampicin using fluorogenic probes

Journal of antimicrobial chemotherapy, 2005-06, Vol.55 (6), p.860-865

2005

Volltextzugriff (PDF)

1 – 25 von 67

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(66)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact médico-économique potentiel d’une organisation stricte du circuit de sortie des patients dans un service de chirurgie urologique

Description des délais de prise en charge des cancers de la prostate en pratique courante

Gold(i)-catalyzed 6-endo-dig azide-yne cyclization: efficient access to 2H-1,3-oxazines

Tolerability of integrase inhibitors in a real-life setting

Do We Need a New Sustainability Assessment Method for the Circular Economy? A Critical Literature Review

Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trial

Body composition changes after switching from protease inhibitors to raltegravir: SPIRAL-LIP substudy

Dual therapy with etravirine plus raltegravir for virologically suppressed HIV-infected patients: a pilot study

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients

A 24-week pilot study of dual maintenance therapy with raltegravir and lamivudine

Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy

Risk of intrauterine growth restriction among HIV-infected pregnant women: a cohort study

Dolutegravir monotherapy in HIV-infected patients with sustained viral suppression

Abacavir-based therapy does not affect biological mechanisms associated with cardiovascular dysfunction

Differential subcutaneous adipose tissue gene expression patterns in a randomized clinical trial of efavirenz or lopinavir-ritonavir in antiretroviral-naive patients

A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/emtricitabine in HIV-1-infected patients with virological suppression

A maintenance 3-day-per-week schedule with the single tablet regimen efavirenz/emtricitabine/tenofovir disoproxil fumarate is effective and decreases sub-clinical toxicity

L’économie Circulaire Est-Elle Bonne Pour l’Environnement? Essais Sur La Mesure De La Circularité

Improvement of lipoatrophy by switching from efavirenz to lopinavir/ritonavir

Incidence and causes of death in HIV‐infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area

Gynecomastia among HIV-Infected Patients Is Associated with Hypogonadism: A Case-Control Study

Metabolic, mitochondrial, renal and hepatic safety of enfuvirtide and raltegravir antiretroviral administration: Randomized crossover clinical trial in healthy volunteers

Subclinical cardiovascular disease in patients starting contemporary protease inhibitors

L’internat d’oncologie en outre-mer français

Direct detection in clinical samples of multiple gene mutations causing resistance of Mycobacterium tuberculosis to isoniazid and rifampicin using fluorogenic probes

Suchergebnisse filtern